News & Analysis on Clinical Trial Services & Contract Research And Development
A new approach to prevent infection of West Nile and dengue fever may be on the horizon after a US team identified interactions involving the alfalfa mosaic virus (AMV). The virus is a close relative of the flaviviruses that cause the killer infections.
NJM/CLI has launched a second product in its range of cottoner systems for the pharmaceutical and nutraceuticals packaging industries.
The safety of cox-2 inhibitors was plunged into further uncertainty after Pfizer released details of trials that found an increased risk of heart problems with patients taking its painkiller Celebrex. The drug is in the same class as Vioxx, which was...
Researchers at AstraZeneca in Sweden have been granted a US patent on a new film coating for tablets that can be carried out in water-based conditions, doing away with the need for use of organic solvent-based systems.
Inpharmatica has announced a discovery collaboration with Novartis Institutes for Biomedical Research which is to focus on identifying protein targets for Novartis' drug discovery projects.
Degussa Homogeneous Catalysts, an internal start-up company operating as part of the Degussa chemical group, introduced a new family of ligands at the CPhI meeting.
Wyeth Pharmaceuticals has announced the submission of a global registration dossier for its investigational antibiotic Tygacil (tigecycline), a new class of treatment for intra-abdominal and skin infections.
France's Flamel Technologies has enrolled the first patient in a clinical trial of its Medusa drug delivery technology, used to develop sustained-release formulations of therapeutic proteins.
DiscoveRx and B-Bridge International are to venture into the Japanese assay market that aims to provide Japanese researchers with a homogenous GPCR and Kinase assay platform for drug development and screening.